Endocrine therapy alone in older adults with good prognosis estrogen receptor-positive breast cancer

被引：0
|
作者：
Israel, Irene [1 ]
Aft, Rebecca [1 ]
机构：
[1] Washington Univ, St Louis, MO 63110 USA
来源：
ANNALS OF SURGICAL ONCOLOGY | 2022年 / 29卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1147322
引用
收藏
页码：75 / 76
页数：2
相关论文
共 50 条
  • [21] Adherence to endocrine therapy and sexual dysfunction in patients older than 65 years with early estrogen receptor-positive breast cancer
    Assad, D. X.
    Dos Santos, D. L.
    Resende, H. M.
    Cesar Moura, F.
    Oliveira, S. C. S.
    Shimada, A. K.
    Arakelian, R.
    Galvao, A. L.
    Wance, B.
    Guimaraes Castro, A.
    Andrade, M. C. F. M. D.
    Cardoso Rodrigues Beckedorff Bittencourt, Y.
    Magalhaes, M. C. F.
    de Padua Souza, C.
    Paiva, C. E.
    Signorini, P.
    Pereira, D. J.
    Rodrigues, A. N.
    Rosa, D. D.
    Barroso-Sousa, R.
    ANNALS OF ONCOLOGY, 2024, 35 : S334 - S334
  • [22] Breast density change as a predictive surrogate for response to adjuvant endocrine therapy in estrogen receptor-positive breast cancer
    Kim, Ji Sun
    Han, Wonshik
    You, Jee Man
    Shin, Hee-Chul
    Ahn, Soo Kyung
    Moon, Hyeong Gon
    Im, Seock-Ah
    Kim, Tae-You
    Cho, Nariya
    Moon, Woo Kyung
    Noh, Dong Young
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [23] Revisiting the estrogen receptor pathway and its role in endocrine therapy for postmenopausal women with estrogen receptor-positive metastatic breast cancer
    Gayathri Nagaraj
    Cynthia Ma
    Breast Cancer Research and Treatment, 2015, 150 : 231 - 242
  • [24] Revisiting the estrogen receptor pathway and its role in endocrine therapy for postmenopausal women with estrogen receptor-positive metastatic breast cancer
    Nagaraj, Gayathri
    Ma, Cynthia
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 150 (02) : 231 - 242
  • [25] Testing Endocrine Response for Managing Primary Estrogen Receptor-Positive Breast Cancer
    Dowsett, Mitch
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (23) : 2520 - +
  • [26] Cardiometabolic Effects of Endocrine Treatment of Estrogen Receptor-Positive Early Breast Cancer
    Cheung, Yee-Ming
    Ramchand, Sabashini K.
    Yeo, Belinda
    Grossmann, Mathis
    JOURNAL OF THE ENDOCRINE SOCIETY, 2019, 3 (07) : 1283 - 1301
  • [27] Kinase fusions drive endocrine resistance in estrogen receptor-positive breast cancer
    Liu, Bo
    Ross, Dara S.
    Schram, Alison M.
    Razavi, Pedram
    Lagana, Stephen M.
    Zhang, Yanming
    Scaltriti, Maurizio
    Bromberg, Jacqueline F.
    Ladanyi, Marc
    Hyman, David M.
    Drilon, Alexander
    Zahir, Ahmet
    Benayed, Ryma
    Hechtman, Jaclyn F.
    Chandarlapaty, Sarat
    CANCER RESEARCH, 2020, 80 (16)
  • [28] Use of endocrine therapy for estrogen receptor-positive breast cancer among American Indians and Alaska natives
    Engelking, Marta
    Marmor, Schelomo
    Burjak, Mohamad
    Hinojos, Madeleine
    Lloyd, Whitney
    Switalla, Kayla M.
    Tuttle, Todd M.
    BREAST CANCER RESEARCH AND TREATMENT, 2023, 198 (02) : 187 - 195
  • [29] Impact of adding the multikinase inhibitor sorafenib to endocrine therapy in metastatic estrogen receptor-positive breast cancer
    Massarweh, Suleiman
    Moss, Jessica
    Wang, Chi
    Romond, Edward
    Slone, Stacey
    Weiss, Heidi
    Karabakhtsian, Rouzan G.
    Napier, Dana
    Black, Esther P.
    FUTURE ONCOLOGY, 2014, 10 (15) : 2435 - 2448
  • [30] Neoadjuvant Endocrine Therapy for Estrogen Receptor-Positive Breast Cancer A Systematic Review and Meta-analysis
    Spring, Laura M.
    Gupta, Arjun
    Reynolds, Kerry L.
    Gadd, Michele A.
    Ellisen, Leif W.
    Isakoff, Steven J.
    Moy, Beverly
    Bardia, Aditya
    JAMA ONCOLOGY, 2016, 2 (11) : 1477 - 1486
12345